CD8A and neoplasm: By analyzing the infiltrating immune cells and the inflammatory immune profiles of tumors, we discovered that anagliptin reduced the proportion of macrophages and the M2/M1 macrophage ratio in the TME, meanwhile, the density of CD8+ T cells infiltrated to tumor was significantly higher in the combinated group compared with the control group.